DOCSLIB.ORG

WORLD GASTROENTEROLOGY NEWS World Digestive Health Day

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WORLD GASTROENTEROLOGY NEWS World Digestive Health Day WORLD GASTROENTEROLOGY NEWS Official e-newsletter of the World Gastroenterology Organisation www.worldgastroenterology.org VOL. 15, ISSUE 4 DECEMBER 2010 In this issue Message from the WDHD Chair World Digestive Health Day (WDHD) 2011: Enteric Infections: prevention and management 2010 World Digestive Health Day Robert Steffen, MD, Hon. FFTM/ACTM Professor Daniel C. Baumgart WDHD 2011 Campaign Director University of Zurich, Switzerland Emeritus Professor of Travel Medicine University of Zurich - Epidemiology and Prevention of Communicable Diseases WHO Collaborating Centre for Travellers’ Health and Adjunct Professor, Epidemiology and Disease Prevention Division University of Texas School of Public Health Houston, TX, U.S.A. IBD Research Review Prof. Jesús K. Yamamoto-Furusho M.D., Ph.D., “Nearly one in five child deaths – about a two week stay in a developing country.3 M.Sc. 1.5 million each year – are due to diar- Enteric infections associated with a rhea. Today, only 39 per cent of children variety of pathogens thus are a global with diarrhea in developing countries problem, no country being unaffected. As receive the recommended treatment, and gastroenterologists anywhere have to deal limited trend data suggest that there has with such diagnoses, the objective of the been little progress since 2000.”1 Enteric WDHD 2011 is to focus attention on the infections, however, occur not only in prevention and management of diarrheal developing countries. In the United States diseases. We will tend to improve child it is estimated that children less than survival in developing countries and also five years in age will have 2.2 episodes of to reduce morbidity and mortality in the Rome Foundation-WGO Joint industrialized world. Special attention will Symposium diarrhea per year; in those above the age of 16 years this rate is still 1.7. German be given to at risk travelers. Obviously the Ami D. Sperber, MD, MSPH sources describe that one third of the strategies will vary in different parts of the total population will have diarrhea at least world. once annually. There were some 16,000 For instance clean water, clean food and deaths from diarrhea recorded in Europe clean environment initiatives will play a in 2002.2 Lastly, travelers originating in greater role in less developed, low resource industrialized countries must expect an countries. Improvement of the infra- incidence rate of travelers’ diarrhea in the structure will reduce the risk of children order of magnitude of 20 to 30% during continued on page 3 2 WORLD GASTROENTEROLOGY NEWS DECEMBER 2010 Contents Editorials World Digestive Health Day 2010 News World Digestive Health Day 01 WDHD 2010: The Year of IBD 09 (WDHD) 2011: Enteric Infections: A Recap of the 2010 IBD Symposium prevention and management Charles N. Bernstein, MD Robert Steffen, MD, Hon WGO & WGOF News World Digestive Health Day 2010: Special Scientific Highlight Greece TTT Review 10 2010 World Digestive Health Day 04 Asian Pacific Digestive Week 2010 13 IBD Task Force Meeting Proceedings Professor Dr KL Goh Professor Daniel C. Baumgart Rome Foundation-WGO Joint 15 IBD Research Review 05 Symposium Ami D. Sperber, MD, MSPH Scientific News Centre International De Formation 17 Post-Graduee En Hepato- Idiopathic Chronic Pancreatitis 06 Gastroenterologie in India and West: Differences Joint WGO-Turkey 2011 Meeeting 18 and Similarities Deepak Bhasin, MD, DM Announcement Surindar S. Rana, MD, DM WGO Global Guidelines Constipation Global Guideline 20 Updates VOL. 15, ISSUE 4 e-WGN Editorial Board Editor: Henry J. Binder, Greger Lindberg • Todd Baron, USA • Klaus Mergener, USA Managing editor: Leah Kopp • Jason Conway, USA • Douglas Rex, USA Art Production: Laura Ludwig • Rodolfo Corti, Argentina • Max Schmulson, Mexico Editorial Office:WGO Executive Secretariat, 555 East Wells • Paul Goldberg, South Africa • Nicholas Shaheen, USA Street, Suite 1100, Milwaukee, WI 53202 USA • Abdel-Meguid Kassem, Egypt • Parul Shukla, India Email: [email protected] • Rene Lambert, France • Martin Smith, South Africa • Joseph Lau, China, Hong Kong • Wendy Spearman, South Africa • Pier-Alberto Testoni, Italy • Nick Talley, USA • Bader Fayaz Zuberi, Pakistan • Mamoru Watanabe, Japan • Chun-Yen Lin, Taiwan ©2010 World Gastroenterology Organisation. No part of this publication may be reproduced. stored in a retrieval system or transmitted in any form without the prior permission of the copyright owner. 3 WORLD GASTROENTEROLOGY NEWS DECEMBER 2010 Editorials | WDHD 2010: Special Scientific Highlight | Scientific News | WDHD 2010 News | WGO & WGOF News | WGO Global Guidelines à Message from the WDHD Chair Continued from page 1 developing the disease in the first place. The World Gastroenterology Organisation selection of the topic for the WDHD is timely: On July 28, 2010 the United Nations General As- sembly declared access to clean water and sanitation a human right. Also vaccines will increasingly play a role in prevention. Still, reducing deaths “depends largely on delivering life-sav- ing treatment of low-osmolarity oral rehydration salts and zinc tablets.”1 While sanitation is not perfect ev- erywhere in industrialized countries, even greater emphasis will be given here on the option of diarrheal pre- vention by vaccines, e.g. the recently Water well in Lamu, Kenya – how safe? introduced one against rotavirus, sometimes also by medication. Thera- peutic guidelines will be propagated, and appropriate travel kits will be rec- REFERENCES: ommended to those planning to visit high-risk countries. A broad range of 1. UNICEF/WHO. Diarrhoea: why children agents including anti-motility agents, are still dying and what can be done. New systemic and non-absorbed antibiot- York/Geneva, 2009 ics, probiotics, absorbents, antisecre- tory agents, etc. need to be discussed 2. WHO. The World Health Report: along the principles of evidence based Changing History. Geneva, 2004 medicine. Thus, gastroenterologists world- 3. Pitzurra R et al. BMC Infect Dis 2010;10:231 wide as ‘Global Guardians of Diges- tive Health’ are expected to greatly contribute to the global fight against enteric infections on May 29, 2011 and throughout next year. 4 WORLD GASTROENTEROLOGY NEWS DECEMBER 2010 Editorials | WDHD 2010: Special Scientific Highlight | Scientific News | WDHD 2010 News | WGO & WGOF News | WGO Global Guidelines 2010 World Digestive Health Day IBD Task Force Meeting Proceedings along with other South Asians who Professor Daniel C. Baumgart live in Europe tend to be more likely Charité Medical Center - Virchow Hospital, Medical School of the to develop IBD than those living in Humboldt-University, Department of Medicine, Division of Gastro- their home countries. He discussed enterology & Hepatology, D-13344 Berlin / Germany there being a resemblance in various E Mail: [email protected] aspects of UC in Pakistan as there is in Western IBD and a noticeable male dominance. It was also mentioned Throughout 2010 e-WGN has CD and low frequency of NOD2 that patients in Pakistan that are brought various articles and scientific polymorphisms in Northern Europe. insured receive access to a majority of information on Inflammatory Bowel approved Western drugs. Disease from around the world to its JAPAN readers. In this issue we look at the Dr. Toshifumi Hibi of Japan spoke PHILIPPINES IBD task force meeting that occurred second and noted that according A challenge in the Philippines, as during Digestive Disease Week 2010 to the Japanese Ministry of Health, Dr. Jose Sollano reported during his in New Orleans, Louisiana, USA, Labor and Welfare the total num- presentation is the limited amount of where leading international research- ber of people affected with IBD is access to specialized care. An interest- ers and specialists gathered to share thought to be more than 100,000. ing fact he brought up is that a major- their view on the disease. The meeting He emphasized that there is almost ity of those with IBD have traveled was also used to plan an IBD Sym- no association between Korean and abroad, whereas those that haven’t posium which was held October Japanese IBD populations in regard tend to be healthy. This leads to the to most identified genes. This leads to 24, 2010 at the United European idea that a non-Philipino style of life the fact that the genetic risk of IBD Gastroenterology Week in Barcelona, or perhaps other infections could be varies greatly between Japanese and Spain (please see the recap on page possible factors. 9). A total of six experts from various Western IBD populations. Dr. Hibi countries gave presentations with ended by giving an overview of the CLOSING REMARKS Dr. Charles Bernstein, Chair of the Japanese management guidelines for The Task Force meeting ended WGO IBD Task Force moderating UC and CD. with a final panel discussion which and several other experts from Austria, LATIN AMERICA included an overall conclusion that Brazil, Canada, France, Germany, Ire- IBD is in fact an issue globally, train- Presenting on the epidemiology of land, Israel, Japan, Malaysia, Mexico, ing and education should continually IBD in Latin America was Dr. Flavio Norway, Pakistan, Philippines and the be supported and national registries Steinwurz of Brazil. He noted that USA engaged in a lively discussion. promoted. Events around the world the areas limited applicability to A brief summary of points from each have continued throughout 2010 the populations within respective presentation follows. which promote IBD education and countries is a major problem when awareness to both physicians as well as discussing epidemiological data and NORWAY to the general public. The WGO con- Latin America. Two more key points The presentation began with Dr. tinues to support this by frequently brought up by Dr. Steinwurz was that Morton H. Vatn of Norway. He sum- seeking updated information to the UC associated cancer is not seen in marized major epidemiological reports IBD Guideline via Graded Evidence Brazil at all, and those that are insured from both North American and Euro- and offering information on its 2010 have access to almost all diagnostic pean groups, discussing incidence rates World Digestive Health Day page.
Load more

Recommended publications
  • Hereditary Pancreatitis
    Fact Sheet - Hereditary Pancreatitis Hereditary Pancreatitis (HP) is a rare genetic condition characterized by recurrent episodes of pancreatic attacks, which can progress to chronic pancreatitis. Symptoms include abdominal pain, nausea, and vomiting. Onset of attacks typically occurs between within the first two decades of life, but can begin at any age. In the United States, it is estimated that at least 1,000 individuals are affected with hereditary pancreatitis. HP has also been linked to an increased lifetime risk of pancreatic cancer. Pancreatic cancer is the 4th leading cause of cancer deaths among Americans. Individuals with hereditary pancreatitis appear to have a 40% lifetime risk of developing pancreatic cancer. This increased risk is heavily dependent upon the duration of chronic pancreatitis and environmental exposures to alcohol and smoking. One recent study suggested that individuals with chronic pancreatitis for more than 25 years had a higher rate of pancreatic cancer when compared to individuals in the general population. This increased rate appears to be due to the prolonged chronic pancreatitis rather than having a gene mutation (all cationic trypsinogen mutations). It is important to note that these risk values may be higher than expected because these studies on pancreatic cancer use a highly selective population rather than a randomly selected population. At this time, there is no cure for HP. Treating the symptoms associated with HP is the choice method of medical management. Patients may be prescribed pancreatic enzyme supplements to treat maldigestion, insulin to treat diabetes, analgesics and narcotics to control pain, and lifestyle changes to reduce the risk of pancreatic cancer (for example, NO SMOKING!).
    [Show full text]
  • Idiopathic and Hereditary Pancreatitis Testing
    Idiopathic and Hereditary Pancreatitis Testing Pancreatitis is a relatively common disorder with multiple etiologies that causes inammation in the pancreas. Acute pancreatitis (AP) is a result of sudden inammation, and patients may present with increased pancreatic enzyme concentrations. Chronic Tests to Consider pancreatitis (CP) is a syndrome of progressive inammation that may lead to permanent damage to pancreatic structure and function. Genetic testing can be utilized to determine Pancreatitis, Panel (CFTR, CTRC, PRSS1, a genetic cause of idiopathic or hereditary AP or CP and/or to assess risk of disease in SPINK1) Sequencing (Temporary Referral as of 12/7/20) 2010876 family members. Method: Polymerase Chain Reaction/Sequencing Preferred test for individuals with history of Disease Overview idiopathic pancreatitis Pancreatitis (CTRC) Sequencing 2010703 Incidence/Prevalence Method: Polymerase Chain Reaction/Sequencing Chronic pancreatitis For adults with idiopathic pancreatitis if other components of panel (CFTR , PRSS1 , SPINK1 ) Incidence: ~4-12/100,000 per year 1 have been sequenced without providing a Prevalence: ~37-42/100,000 1 complete explanation for the pancreatitis Idiopathic chronic pancreatitis is more common than previously thought 2 Pancreatitis (PRSS1) Sequencing and Deletion/Duplication (Temporary Referral Symptoms/Presentation Etiologies as of 01/14/21) 3001768 Method: Polymerase Chain Reaction/Sequencing Acute Sudden onset of pain in Common and Multiplex Ligation Dependent Probe Amplic- pancreatitis the upper abdomen,
    [Show full text]
  • Hereditary Pancreatitis: Outcomes and Risks
    HEREDITARY PANCREATITIS: OUTCOMES AND RISKS by Celeste Alexandra Shelton BS, University of Pittsburgh, 2013 Submitted to the Graduate Faculty of the Graduate School of Public Health in partial fulfillment of the requirements for the degree of Master of Science University of Pittsburgh 2015 UNIVERSITY OF PITTSBURGH Graduate School of Public Health This thesis was presented by Celeste Alexandra Shelton It was defended on April 7, 2015 and approved by Thesis Director David C. Whitcomb, MD, PhD, Chief, Division of Gastroenterology, Hepatology and Nutrition, Giant Eagle Foundation Professor of Cancer Genetics, Professor of Medicine, Cell Biology & Physiology and Human Genetics, School of Medicine, University of Pittsburgh Committee Members Randall E. Brand, MD, Professor of Medicine, School of Medicine, University of Pittsburgh, Academic Director, GI-Division, UPMC Shadyside, Dir., GI Malignancy Early Detection, Diagnosis & Prevention Program, Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Robin E. Grubs, PhD, LCGC, Assistant Professor, Director, Genetic Counseling Program, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh John R. Shaffer, PhD, Assistant Professor, Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh ii Copyright © by Celeste Shelton 2015 iii HEREDITARY PANCREATITIS: OUTCOMES AND RISKS Celeste A. Shelton, MS University of Pittsburgh, 2015 ABSTRACT Pancreatitis is an inflammatory disease of the pancreas that was first identified in the 1600s. Symptoms for pancreatitis include intense abdominal pain, nausea, and malnutrition. Hereditary pancreatitis (HP) is a genetic condition in which recurrent acute attacks can progress to chronic pancreatitis, typically beginning in adolescence. Mutations in the PRSS1 gene cause autosomal dominant HP.
    [Show full text]
  • Prevalence of Pancreatitis in Female and Male Pediatric Patients in Eastern Kentucky in the United States
    Central Journal of Family Medicine & Community Health Research Article *Corresponding author Karin N. Westlund, Department of Physiology, University of Kentucky, MS-508 Medical Science Building, 800 Prevalence of Pancreatitis in Rose, Lexington, KY, 40536-0298, USA, Tel: 859-323-0672 or -33668; Email: Submitted: 23 August 2016 Female and Male Pediatric Accepted: 10 November 2016 Published: 12 November 2016 Patients in Eastern Kentucky in ISSN: 2379-0547 Copyright the United States © 2016 Westlund et al. OPEN ACCESS Sabrina L. McIlwrath and Karin N. Westlund* Department of Physiology, University of Kentucky, USA Keywords • Epidemiology • Gender difference Abstract • Recurrent acute pancreatitis Background & aims: Studies in the past decade report worldwide increase of • Tobacco use pediatric pancreatitis. The present study focuses on aUnited States region where the • Obesity first genes associated with hereditary pancreatitis were identified. Aim of the study was to investigate incidences of acute pancreatitis, recurrent acute pancreatitis, and chronic pancreatitis, collecting demographics, etiologies, and comorbid conditions using charted ICD-9-CM codes. Methods: Retrospective chart review was performed on de-identified patient records of hospitalizations at University of Kentucky hospitals between 2005 and 2013. Results: Of 234 children diagnosed during the 9 year time period, 69.2% (n=162) had a single episode of acute, 27.8% (65) recurrent acute, and 16.2% (38) chronic pancreatitis. Surprisingly, the annual incidence for first time diagnosis of acute pancreatitis was significantly higher for female patients (16.1, 95% CI: 13.5- 18.7 per 100,000, P<0.005) compared to males (9.1, 95% CI: 6.8-11.4). Comorbid conditions varied widely depending on patients’ age.
    [Show full text]
  • Genetic Testing for Hereditary Pancreatitis
    Genetic Testing for Hereditary Pancreatitis Last Review Date: October 12, 2018 Number: MG.MM.LA.28C3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth the clinical evidence that the patient meets the criteria for the treatment or surgical procedure. Without this documentation and information, EmblemHealth will not be able to properly review the request for prior authorization. The clinical review criteria expressed below reflects how EmblemHealth determines whether certain services or supplies are medically necessary. EmblemHealth established the clinical review criteria based upon a review of currently available clinical information (including clinical outcome studies in the peer-reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research agencies, evidence- based guidelines and positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas, and other relevant factors). EmblemHealth expressly reserves the right to revise these conclusions as clinical information changes, and welcomes further relevant information. Each benefit program defines which services are covered. The conclusion that a particular service or supply is medically necessary does not constitute a representation or warranty that this service or supply is covered and/or paid for by EmblemHealth, as some programs exclude coverage for services or supplies that EmblemHealth considers medically necessary. If there is a discrepancy between this guideline and a member's benefits program, the benefits program will govern. In addition, coverage may be mandated by applicable legal requirements of a state, the Federal Government or the Centers for Medicare & Medicaid Services (CMS) for Medicare and Medicaid members.
    [Show full text]
  • Abdominal Pain
    10 Abdominal Pain Adrian Miranda Acute abdominal pain is usually a self-limiting, benign condition that irritation, and lateralizes to one of four quadrants. Because of the is commonly caused by gastroenteritis, constipation, or a viral illness. relative localization of the noxious stimulation to the underlying The challenge is to identify children who require immediate evaluation peritoneum and the more anatomically specific and unilateral inner- for potentially life-threatening conditions. Chronic abdominal pain is vation (peripheral-nonautonomic nerves) of the peritoneum, it is also a common complaint in pediatric practices, as it comprises 2-4% usually easier to identify the precise anatomic location that is produc- of pediatric visits. At least 20% of children seek attention for chronic ing parietal pain (Fig. 10.2). abdominal pain by the age of 15 years. Up to 28% of children complain of abdominal pain at least once per week and only 2% seek medical ACUTE ABDOMINAL PAIN attention. The primary care physician, pediatrician, emergency physi- cian, and surgeon must be able to distinguish serious and potentially The clinician evaluating the child with abdominal pain of acute onset life-threatening diseases from more benign problems (Table 10.1). must decide quickly whether the child has a “surgical abdomen” (a Abdominal pain may be a single acute event (Tables 10.2 and 10.3), a serious medical problem necessitating treatment and admission to the recurring acute problem (as in abdominal migraine), or a chronic hospital) or a process that can be managed on an outpatient basis. problem (Table 10.4). The differential diagnosis is lengthy, differs from Even though surgical diagnoses are fewer than 10% of all causes of that in adults, and varies by age group.
    [Show full text]
  • Clinical Genetic Testing in Gastroenterology
    Clinical Genetic Testing in Gastroenterology The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Goodman, Russell P., and Daniel C Chung. 2016. “Clinical Genetic Testing in Gastroenterology.” Clinical and Translational Gastroenterology 7 (4): e167. doi:10.1038/ctg.2016.23. http:// dx.doi.org/10.1038/ctg.2016.23. Published Version doi:10.1038/ctg.2016.23 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320331 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Citation: Clinical and Translational Gastroenterology (2016) 7, e167; doi:10.1038/ctg.2016.23 & 2016 the American College of Gastroenterology All rights reserved 2155-384X/16 www.nature.com/ctg CLINICAL AND SYSTEMATIC REVIEWS Clinical Genetic Testing in Gastroenterology Russell P. Goodman, MD, DPhil1 and Daniel C. Chung, MD1 Rapid advances in genetics have led to an increased understanding of the genetic determinants of human disease, including many gastrointestinal (GI) disorders. Coupled with a proliferation of genetic testing services, this has resulted in a clinical landscape where commercially available genetic tests for GI disorders are now widely available. In this review, we discuss the current status of clinical genetic testing for GI illnesses, review the available testing options, and briefly discuss indications for and practical aspects of such testing. Our goal is to familiarize the practicing gastroenterologist with this rapidly changing and important aspect of clinical care.
    [Show full text]
  • Progress Report Genetics and Gastroenterology
    Gut: first published as 10.1136/gut.12.7.592 on 1 July 1971. Downloaded from Gut, 1971, 12, 592-598 Progress report Genetics and gastroenterology The decade since the last review of this subject in Gut has seen considerable advances in many aspects of genetics, including the influence of heredity on disease. Compared with some specialties gastroenterology has few disorders with simple Mendelian inheritance, but in most of its conditions there is some hereditary influence. Some of the best human data illustrating a quantitative type of disease liability are those on hypertrophic pyloric stenosis and Hirschsprung's disease, and the discovery of two of the genes of the genotype giving susceptibility to duodenal ulcer is still unique. There is growing realization that both heredity and environmental factors are concerned in the aetiology of most disorders. Blood Groups and Alimentary Physiology It is still not clear what part the ABO blood group genes and the genes at the secretor, H, and Lewis loci play in alimentary physiology1. It would seem likely that they are concerned via their control of the arrangement of the sugars on the molecules of the mucus of the upper part of the tract. Yet one would not expect such slight variations between the different group specific http://gut.bmj.com/ molecules to affect their physicochemical properties. Furthermore, the dis- covery of the close relationship between the serum content ofjejunal alkaline phosphatase and the ABO blood group and secretor status2,3,4 suggests that the blood group genes are pleiotropic. In addition to their well known, and possibly unimportant, effect on the serological specificity of glycoproteins, these genes may be concerned in more fundamental processes such as the on October 2, 2021 by guest.
    [Show full text]
  • A Clinical Study of Chronic Pancreatitis
    Gut: first published as 10.1136/gut.4.3.193 on 1 September 1963. Downloaded from Gut, 1963, 4, 193 A clinical study of chronic pancreatitis OLIVER FITZGERALD, PATRICK FITZGERALD, JAMES FENNELLY1, JOSEPH P. McMULLIN, AND SYLVESTER J. BOLAND From St. Vincent's Hospital and the Departments of Medicine and Therapeutics and ofSurgery, University College, Dublin EDITORIAL SYNOPSIS A series of 53 cases of chronic pancreatic disease is described and attention drawn to the frequency with which symptoms are persistent rather than intermittent. A plea is made for the use of the term 'progressive' rather than 'relapsing' in describing many of these cases. Alcohol was an unimportant factor in the aetiology. The possibility of achieving an accurate and early diagnosis using the serum secretin/pancreozymin test is emphasized. The frequent relief of symptoms and the prevention of progress of the disease by surgery, especially sphincterotomy, is recorded. While pancreatitis has been recognized for over a (Howat, 1952; Burton, Hammond, Harper, Howat, century as a cause of gastro-intestinal disturbance, Scott, and Varley, 1960). much of the literature has dealt with acute rather In this paper we propose to describe our experi- than with chronic pancreatic disease. Reports on ence with 53 cases of chronic pancreatitis, laying the latter have been published by Comfort, Gambill, particular stress on the possibility and importance and Baggenstoss (1946), by Gambill, Comfort, and of early diagnosis of the condition, that is, when Baggenstoss (1948), and by Janowitz and Dreiling minimal damage to the acinar and islet tissues has http://gut.bmj.com/ (1958) but there is still disagreement as to the usual been caused.
    [Show full text]
  • Idiopathic Acute Pancreatitis: a Review on Etiology and Diagnostic Work-Up
    Clinical Journal of Gastroenterology (2019) 12:511–524 https://doi.org/10.1007/s12328-019-00987-7 CLINICAL REVIEW Idiopathic acute pancreatitis: a review on etiology and diagnostic work‑up Giovanna Del Vecchio Blanco1 · Cristina Gesuale1 · Marzia Varanese1 · Giovanni Monteleone1 · Omero Alessandro Paoluzi1 Received: 30 January 2019 / Accepted: 19 April 2019 / Published online: 30 April 2019 © Japanese Society of Gastroenterology 2019 Abstract Acute pancreatitis (AP) is a common disease associated with a substantial medical and fnancial burden, and with an inci- dence across Europe ranging from 4.6 to 100 per 100,000 population. Although most cases of AP are caused by gallstones or alcohol abuse, several other causes may be responsible for acute infammation of the pancreatic gland. Correctly diagnosing AP etiology is a crucial step in the diagnostic and therapeutic work-up of patients to prescribe the most appropriate therapy and to prevent recurrent attacks leading to the development of chronic pancreatitis. Despite the improvement of diagnostic technologies, and the availability of endoscopic ultrasound and sophisticated radiological imaging techniques, the etiology of AP remains unclear in ~ 10–30% of patients and is defned as idiopathic AP (IAP). The present review aims to describe all the conditions underlying an initially diagnosed IAP and the investigations to consider during diagnostic work-up in patients with non-alcoholic non-biliary pancreatitis. Keywords Acute pancreatitis · Endoscopic ultrasonography · Idiopathic pancreatitis
    [Show full text]
  • Hereditary Pancreatitis
    Lab Management Guidelines v2.0.2019 Genetic Testing for Hereditary Pancreatitis MOL.TS.287.A v2.0.2019 Introduction Genetic testing for hereditary pancreatitis is addressed by this guideline. Procedures addressed The inclusion of any procedure code in this table does not imply that the code is under management or requires prior authorization. Refer to the specific Health Plan's procedure code list for management requirements. Procedures addressed by this Procedure codes guideline CASR Sequencing 81405 CFTR Deletion/Duplication Analysis 81222 CFTR Known Familial Mutation Analysis 81221 CFTR Sequencing 81223 CFTR Targeted Mutation Analysis 81479 CLDN2 Sequencing 81479 CPA1 Sequencing 81479 CTRC Known Familial Mutation Analysis 81403 CTRC Sequencing 81405 PRSS1 Deletion/Duplication Analysis 81479 PRSS1 Known Familial Mutation Analysis 81403 PRSS1 Sequencing 81404 PRSS1 Targeted Mutation Analysis 81401 SPINK1 Deletion/Duplication Analysis 81479 SPINK1 Known Familial Mutation Analysis 81403 SPINK1 Sequencing 81404 © eviCore healthcare. All Rights Reserved. 1 of 12 400 Buckwalter Place Boulevard, Bluffton, SC 29910 (800) 918-8924 www.eviCore.com Lab Management Guidelines v2.0.2019 What is pancreatitis Definition Pancreatitis is inflammation of the pancreas that may be acute, acute recurrent, or chronic.1 Acute pancreatitis is defined as two of the three following findings:2 Abdominal pain Elevated serum amylase or lipase (greater than 3x the upper limit of normal) Findings consistent with pancreatic inflammation on abdominal imaging Acute recurrent pancreatitis is defined as multiple (2 or more), discrete episodes of acute pancreatitis without any evidence of chronic pancreatitis. There must be complete resolution of clinical and laboratory findings between episodes. Chronic pancreatitis is defined as an irreversible fibro-inflammatory process which leads to permanent changes in the pancreatic parenchyma and function.
    [Show full text]
  • FINAL Vop Pancreatitis Report
    The meeting was made possible by the following sponsors: The meeting & report were supported by the following partners: TITLE: Pancreatitis Externally-Led, Patient-Focused Drug Development Meeting Contributors National Pancreas Foundation Dana K. Andersen, MD, Board of Chair David Bakelman, CEO Brooke Campbell, National Programs Coordinator Jane Holt, Co-Founder Sokphal Tun, National Program Director FCS Foundation Melissa Goetz, Co-President Mission: Cure Megan Golden, Co-Director Linda Martin, Co-Director Rebecca’s Wish Christyn Taylor, President Consulting Partners Health and Medicine Counsel of Washington: Dale Dirks and Dane Christiansen Hyman, Phelps & McNamara, P.C.: James Valentine, JD, MHS and Larry Bauer, RN, MA Disclosures No company received any benefits from supporting the EL-PFDD meeting and none were involved in the planning of the meeting. The National Pancreas Foundation, FCS Foundation, Mission: Cure, and Rebecca’s Wish are non-profit patient advocacy organizations that receive funding from pharmaceutical companies in the form of unrestricted grants and sponsorship of programs and events. Dale Dirks and Dane Christiansen are employed by the Health and Medicine Counsel, a government relations firm that primarily represents non-profits patient organizations in advocacy efforts. They provided technical assistance and advice as NPF planned the meeting and reviewed the Voice of the Patient report. James Valentine and Larry Bauer are employed by Hyman, Phelps & McNamara, P.C., a law firm that represents sponsors development drugs and patient advocacy organizations. These organizations helped fund the cost of the Externally-Led PFDD meeting: Abbvie, ChiRhoClin, Inc., Digestive Care Inc., Sagent Disclosures: No company received and benefits from supporting the PFDD meeting and were not involved in the coordination of the meeting Published: October 2020.
    [Show full text]